US12296050 — Pharmaceutical compositions comprising maralixibat and uses thereof
Method of Use · Assigned to Mirum Pharmaceuticals Inc · Expires 2043-10-05 · 17y remaining
What this patent protects
This patent protects a pharmaceutical composition containing maralixibat or a salt thereof, used as a solid dosage drug product for treating cholestatic pruritus and liver disease.
USPTO Abstract
The invention relates to a pharmaceutical composition comprising maralixibat, or a pharmaceutically acceptable salt thereof, as the active ingredient. The invention further relates to the use of the pharmaceutical composition as a solid dosage drug product. The invention also relates to the use of the pharmaceutical composition and the solid dosage drug product described herein for treating cholestatic pruritus and cholestatic liver disease.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-4187 |
— | maralixibat-chloride |
U-4187 |
— | maralixibat-chloride |
U-4186 |
— | maralixibat-chloride |
U-4187 |
— | maralixibat-chloride |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.